ENTO ENTERO THERAPEUTICS INC Company Mergers 8-K Filing 2023 - Acquisition of ImmunogenX, Inc. First Wave BioPharma, Inc. has entered into a non-binding letter of intent for a proposed acquisition with ImmunogenX, Inc. to acquire 100% of the outstanding equity of IMGX, with the shareholders of IMGX owning a majority of the combined company. James Sapirstein will continue as Chairman and CEO, and Jack Syage will become President and COO.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC